XBiotech Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of XBIT?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,944,63016.2%
Individual Insiders10,635,03134.9%
General Public14,903,82048.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 50.25% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.8%
Thomas Gut
3,914,111US$25.0m0%no data
12.5%
John Simard
3,823,166US$24.4m0%no data
8.65%
W. McKenzie
2,637,011US$16.8m0%no data
4.1%
BlackRock, Inc.
1,250,001US$8.0m10.2%no data
3.48%
The Vanguard Group, Inc.
1,061,979US$6.8m2.41%no data
1.48%
Geode Capital Management, LLC
452,264US$2.9m5.13%no data
0.92%
Millennium Management LLC
281,019US$1.8m-22.3%no data
0.88%
UBS Asset Management AG
268,195US$1.7m3.59%no data
0.74%
State Street Global Advisors, Inc.
224,595US$1.4m10.7%no data
0.69%
Bridgeway Capital Management, LLC
210,143US$1.3m-5.9%0.02%
0.66%
Jan-Paul Waldin
200,243US$1.3m0%no data
0.6%
Northern Trust Global Investments
183,567US$1.2m134%no data
0.43%
Morgan Stanley, Investment Banking and Brokerage Investments
130,530US$832.8k30.1%no data
0.43%
American Century Investment Management Inc
130,183US$830.6k70.3%no data
0.28%
BNY Asset Management
84,732US$540.6k-13.8%no data
0.25%
Connor, Clark & Lunn Investment Management Ltd.
75,715US$483.1k-2.58%no data
0.24%
Dimensional Fund Advisors LP
72,475US$462.4k0%no data
0.22%
Mckenzie Charitable Foundation, Endowment Arm
66,748US$425.8k0%no data
0.19%
Charles Schwab Investment Management, Inc.
58,437US$372.8k7.94%no data
0.13%
Goldman Sachs Group, Investment Banking and Securities Investments
40,418US$257.9k207%no data
0.13%
BNP Paribas Arbitrage Sa, Asset Management Arm
40,040US$255.5k185%no data
0.11%
National Bank Investments Inc.
33,000US$210.5k0%no data
0.095%
FMR LLC
28,992US$185.0k34.4%no data
0.086%
Barclays PLC Private Banking & Investment Banking Investment
26,343US$168.1k307%no data
0.084%
Angela Hu
25,500US$162.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 23:18
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

XBiotech Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaNOBLE Capital Markets, Inc.
Joseph CatanzaroPiper Sandler Companies